{
  "docId": "019de075-ba14-74ac-bf24-b9a07d855845",
  "docSlug": "ce85efab4cdfea0a9273e6eac7085298",
  "documentTitle": "MindMed | Investor Presentation Deck | 32 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 32,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a Gantt-style chart to show the progress of various drug candidates through clinical development stages.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-ba14-74ac-bf24-b9a07d855845/5",
  "deckHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845",
  "deckJsonHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845.json",
  "deckAnchorHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.631,
        "w": 0.886,
        "x": 0.057,
        "y": 0.171
      },
      "kind": "chart",
      "text": "Pipeline progress chart",
      "attrs": null,
      "subkind": "gantt-chart",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7dacad0e-8606-4944-9f89-5bb146f2b3d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.697,
        "x": 0.057,
        "y": 0.088
      },
      "kind": "paragraph",
      "text": "Our pipeline diversification offers potential opportunities across therapeutic areas and mechanisms of action",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4ba89fc-9f03-440d-84b1-049ea3d9d793",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.56,
        "x": 0.057,
        "y": 0.835
      },
      "kind": "source-note",
      "text": "* Continued development of MM-110 is currently subject to the Company obtaining non-dilutive sources of capital and/or collaboration partners. ** Full trial details and clinical trials.gov links available at mindmed.co/clinical-digital-trials/",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45e896da-6768-43f4-9b88-9c0a576070a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.47,
        "x": 0.057,
        "y": 0.878
      },
      "kind": "source-note",
      "text": "ADHD: Attention-Deficit/Hyperactivity Disorder; LSD: lysergic acid diethylamide; MDMA: 3,4-methylenedioxymethamphetamine",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "936b877f-7ee8-4359-a0ac-78c1bd21c13f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.465,
        "x": 0.057,
        "y": 0.035
      },
      "kind": "title",
      "text": "Research & Development Pipeline",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d731a9a5-c3b3-4247-84ff-4905722e868f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "2197b234-016d-4d16-8afa-462ca7bfe9cb",
      "evidence": "Visual representation of project timelines across phases",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 5,
      "beatId": "7bac0740-fd1e-4a5a-a03b-24bd31952c12",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The deck highlights the significant market potential for MindMed's treatments.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 11,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5f504a9c-3843-44a1-a98b-05d619e8c17d",
      "evidence": "The deck highlights the limitations of current treatments and the significant unmet need.",
      "position": 0,
      "objective": "What are the consequences of not addressing the urgent need for better treatments?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 10,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ef05f44f-e58a-472e-8ce8-ca34828417f4",
      "evidence": "The deck presents MindMed's lead candidate and emerging treatment paradigm as a solution to the problem.",
      "position": 1,
      "objective": "Why is MindMed's approach necessary and effective?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}